Found: 552
Select item for more details and to access through your institution.
Interdisciplinary Engagement In Neurocardiology: A Key Opportunity.
- Published in:
- Journal of the American Heart Association, 2024, v. 13, n. 17, p. 1, doi. 10.1161/JAHA.124.034804
- By:
- Publication type:
- Article
Colchicine for cardiovascular and limb risk reduction in Medicare beneficiaries with peripheral artery disease: emulation of target trials.
- Published in:
- European Heart Journal Open, 2024, v. 4, n. 4, p. 1, doi. 10.1093/ehjopen/oeae062
- By:
- Publication type:
- Article
Comparison of change in lipoprotein(a) mass and molar concentrations by alirocumab and risk of subsequent cardiovascular events in ODYSSEY OUTCOMES.
- Published in:
- European Journal of Preventive Cardiology, 2024, v. 31, n. 10, p. e75, doi. 10.1093/eurjpc/zwae110
- By:
- Publication type:
- Article
The efficacy and safety of dapagliflozin in women and men with type 2 diabetes mellitus.
- Published in:
- Diabetologia, 2021, v. 64, n. 6, p. 1226, doi. 10.1007/s00125-021-05399-2
- By:
- Publication type:
- Article
The Cost-Effectiveness of Rivaroxaban Plus Aspirin Compared with Aspirin Alone in the COMPASS Trial: A US Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2024, v. 24, n. 1, p. 117, doi. 10.1007/s40256-023-00620-6
- By:
- Publication type:
- Article
Cost-Consequence Analysis of Using Cangrelor in High Angiographic Risk Percutaneous Coronary Intervention Patients: A US Hospital Perspective.
- Published in:
- American Journal of Cardiovascular Drugs, 2022, v. 22, n. 1, p. 93, doi. 10.1007/s40256-021-00491-9
- By:
- Publication type:
- Article
Predictors of Annual Pharmaceutical Costs in Australia for Community-Based Individuals with, or at Risk of, Cardiovascular Disease.
- Published in:
- American Journal of Cardiovascular Drugs, 2010, v. 10, n. 2, p. 85, doi. 10.2165/11530670-000000000-00000
- By:
- Publication type:
- Article
Aspirin and Platelet Adenosine Diphosphate Receptor Antagonists in Acute Coronary Syndromes and Percutaneous Coronary Intervention: Role in Therapy and Strategies to Overcome Resistance.
- Published in:
- American Journal of Cardiovascular Drugs, 2008, v. 8, n. 2, p. 91, doi. 10.1007/BF03256587
- By:
- Publication type:
- Article
Long-Term Benefit of Statin Therapy Initiated during Hospitalization for an Acute Coronary Syndrome: A Systematic Review of Randomized Trials.
- Published in:
- American Journal of Cardiovascular Drugs, 2007, v. 7, n. 2, p. 135, doi. 10.2165/00129784-200707020-00005
- By:
- Publication type:
- Article
Clopidogrel Bisulfate In ST-Segment Elevation Myocardial Infarction: A Viewpoint by Deepak L. Bhatt.
- Published in:
- 2006
- By:
- Publication type:
- Editorial
Antiplatelet Agents in Patients Undergoing Percutaneous Coronary Intervention: How Many and How Much?
- Published in:
- American Journal of Cardiovascular Drugs, 2005, v. 5, n. 5, p. 307, doi. 10.2165/00129784-200505050-00003
- By:
- Publication type:
- Article
Effect of sotagliflozin on albuminuria in patients with type 2 diabetes and chronic kidney disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 11, p. 3410, doi. 10.1111/dom.15203
- By:
- Publication type:
- Article
Semaglutide reduces the risk of major adverse cardiovascular events consistently across baseline triglyceride levels in patients with type 2 diabetes: Post hoc analyses of the SUSTAIN 6 and PIONEER 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 8, p. 2388, doi. 10.1111/dom.15081
- By:
- Publication type:
- Article
Use of optimal medical therapy in patients with diabetes and atherosclerotic cardiovascular disease: Insights from a prospective longitudinal cohort study.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 6, p. 1750, doi. 10.1111/dom.15032
- By:
- Publication type:
- Article
Potential for residual cardiovascular risk reduction: Eligibility for icosapent ethyl in the VERTIS CV population with type 2 diabetes and atherosclerotic cardiovascular disease.
- Published in:
- Diabetes, Obesity & Metabolism, 2023, v. 25, n. 5, p. 1398, doi. 10.1111/dom.14965
- By:
- Publication type:
- Article
Re‐examining the widespread policy of stopping sodium‐glucose cotransporter‐2 inhibitors during acute illness: A perspective based on the updated evidence.
- Published in:
- Diabetes, Obesity & Metabolism, 2022, v. 24, n. 11, p. 2071, doi. 10.1111/dom.14805
- By:
- Publication type:
- Article
The cost‐effectiveness of dapagliflozin in treating high‐risk patients with type 2 diabetes mellitus: An economic evaluation using data from the DECLARE‐TIMI 58 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 4, p. 1020, doi. 10.1111/dom.14308
- By:
- Publication type:
- Article
Cardiorenal outcomes with dapagliflozin by baseline glucose‐lowering agents: Post hoc analyses from DECLARE‐TIMI 58.
- Published in:
- Diabetes, Obesity & Metabolism, 2021, v. 23, n. 1, p. 29, doi. 10.1111/dom.14179
- By:
- Publication type:
- Article
Effects of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across body mass index categories in type 2 diabetes: Results of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 12, p. 2487, doi. 10.1111/dom.14160
- By:
- Publication type:
- Article
The effect of glucagon‐like peptide‐1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 9, p. 1690, doi. 10.1111/dom.14079
- By:
- Publication type:
- Article
Safety of dapagliflozin in a broad population of patients with type 2 diabetes: Analyses from the DECLARE‐TIMI 58 study.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 8, p. 1357, doi. 10.1111/dom.14041
- By:
- Publication type:
- Article
Cardiovascular and renal benefits of dapagliflozin in patients with short and long‐standing type 2 diabetes: Analysis from the DECLARE‐TIMI 58 trial.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1122, doi. 10.1111/dom.14011
- By:
- Publication type:
- Article
Association between uric acid levels and cardio‐renal outcomes and death in patients with type 2 diabetes: A subanalysis of EMPA‐REG OUTCOME.
- Published in:
- Diabetes, Obesity & Metabolism, 2020, v. 22, n. 7, p. 1207, doi. 10.1111/dom.13991
- By:
- Publication type:
- Article
Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: A nationwide study.
- Published in:
- Diabetes, Obesity & Metabolism, 2019, v. 21, n. 9, p. 2058, doi. 10.1111/dom.13765
- By:
- Publication type:
- Article
DECLARE‐TIMI 58: Participants’ baseline characteristics.
- Published in:
- Diabetes, Obesity & Metabolism, 2018, v. 20, n. 5, p. 1102, doi. 10.1111/dom.13217
- By:
- Publication type:
- Article
Hypoglycaemia manifestations and recurrent events: Lessons from the SAVOR-TIMI 53 outcome study.
- Published in:
- Diabetes, Obesity & Metabolism, 2017, v. 19, n. 7, p. 1045, doi. 10.1111/dom.12903
- By:
- Publication type:
- Article
Bariatric surgery vs. advanced practice medical management in the treatment of type 2 diabetes mellitus: rationale and design of the Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently trial (STAMPEDE).
- Published in:
- Diabetes, Obesity & Metabolism, 2010, v. 12, n. 5, p. 452, doi. 10.1111/j.1463-1326.2009.01172.x
- By:
- Publication type:
- Article
CS1, a controlled‐release formulation of valproic acid, for the treatment of patients with pulmonary arterial hypertension: Rationale and design of a Phase 2 clinical trial.
- Published in:
- Pulmonary Circulation, 2024, v. 14, n. 1, p. 1, doi. 10.1002/pul2.12323
- By:
- Publication type:
- Article
Effect of Rimonabant on Progression of Atherosclerosis in Patients With Abdominal Obesity and Coronary Artery Disease.
- Published in:
- JAMA: Journal of the American Medical Association, 2008, v. 299, n. 13, p. 1547, doi. 10.1001/jama.299.13.1547
- By:
- Publication type:
- Article
One-Year Cardiovascular Event Rates in Outpatients With Atherothrombosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 11, p. 1197, doi. 10.1001/jama.297.11.1197
- By:
- Publication type:
- Article
International Prevalence, Recognition, and Treatment of Cardiovascular Risk Factors in Outpatients With Atherothrombosis.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 2, p. 180, doi. 10.1001/jama.295.2.180
- By:
- Publication type:
- Article
To Cath or Not to Cath: That Is No Longer the Question.
- Published in:
- JAMA: Journal of the American Medical Association, 2005, v. 293, n. 23, p. 2935, doi. 10.1001/jama.293.23.2935
- By:
- Publication type:
- Article
Utilization of Early Invasive Management Strategies for High-Risk Patients With Non–ST-Segment Elevation Acute Coronary Syndromes: Results From the CRUSADE Quality Improvement Initiative.
- Published in:
- JAMA: Journal of the American Medical Association, 2004, v. 292, n. 17, p. 2096, doi. 10.1001/jama.292.17.2096
- By:
- Publication type:
- Article
An evidence-based score to detect prevalent peripheral artery disease (PAD).
- Published in:
- Vascular Medicine, 2012, v. 17, n. 5, p. 342, doi. 10.1177/1358863X12445102
- By:
- Publication type:
- Article
Carotid plaque and intima-media thickness and the incidence of ischemic events in patients with atherosclerotic vascular disease.
- Published in:
- Vascular Medicine, 2011, v. 16, n. 5, p. 323, doi. 10.1177/1358863X11419997
- By:
- Publication type:
- Article
Influence of polyvascular disease on cardiovascular event rates. Insights from the REACH Registry.
- Published in:
- Vascular Medicine, 2010, v. 15, n. 4, p. 259, doi. 10.1177/1358863X10373299
- By:
- Publication type:
- Article
Clinical evidence for anti-inflammatory effects of antiplatelet therapy in patients with atherothrombotic disease.
- Published in:
- Vascular Medicine, 2007, v. 12, n. 2, p. 113, doi. 10.1177/1358863X07077462
- By:
- Publication type:
- Article
Percutaneous thrombin injection for pseudoaneurysm repair.
- Published in:
- Vascular Medicine, 2003, v. 8, n. 3, p. 217, doi. 10.1191/1358863x03vm484xx
- By:
- Publication type:
- Article
An explainable machine learning-based phenomapping strategy for adaptive predictive enrichment in randomized clinical trials.
- Published in:
- NPJ Digital Medicine, 2023, v. 6, n. 1, p. 1, doi. 10.1038/s41746-023-00963-z
- By:
- Publication type:
- Article
Predicting radiocephalic arteriovenous fistula success with machine learning.
- Published in:
- NPJ Digital Medicine, 2022, v. 5, n. 1, p. 1, doi. 10.1038/s41746-022-00710-w
- By:
- Publication type:
- Article
Trends in Stroke Thrombolysis Care Metrics and Outcomes by Race and Ethnicity, 2003-2021.
- Published in:
- JAMA Network Open, 2024, v. 7, n. 2, p. e2352927, doi. 10.1001/jamanetworkopen.2023.52927
- By:
- Publication type:
- Article
Temporal Association Among Influenza-Like Illness, Cardiovascular Events, and Vaccine Dose in Patients With High-Risk Cardiovascular Disease: Secondary Analysis of a Randomized Clinical Trial.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 9, p. e2331284, doi. 10.1001/jamanetworkopen.2023.31284
- By:
- Publication type:
- Article
Pleiotropic Effects of Influenza Vaccination.
- Published in:
- Vaccines, 2023, v. 11, n. 9, p. 1419, doi. 10.3390/vaccines11091419
- By:
- Publication type:
- Article
Dabigatran Dual Therapy vs Warfarin Triple Therapy Post-Percutaneous Coronary Intervention in Patients with Atrial Fibrillation With/Without a Proton Pump Inhibitor: A Pre-Specified Analysis of the RE-DUAL PCI Trial.
- Published in:
- Drugs, 2020, v. 80, n. 10, p. 995, doi. 10.1007/s40265-020-01323-x
- By:
- Publication type:
- Article
Liraglutide to Improve corONary haemodynamics during Exercise streSS (LIONESS): a double-blind randomised placebo-controlled crossover trial.
- Published in:
- Diabetology & Metabolic Syndrome, 2021, v. 13, n. 1, p. 1, doi. 10.1186/s13098-021-00635-6
- By:
- Publication type:
- Article
Nonobstructive Coronary Artery Disease and Risk of Myocardial Infarction.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 312, n. 17, p. 1754, doi. 10.1001/jama.2014.14681
- By:
- Publication type:
- Article
Door-to-Needle Times for Tissue Plasminogen Activator Administration and Clinical Outcomes in Acute Ischemic Stroke Before and After a Quality Improvement Initiative.
- Published in:
- JAMA: Journal of the American Medical Association, 2014, v. 311, n. 16, p. 1632, doi. 10.1001/jama.2014.3203
- By:
- Publication type:
- Article
Dual antiplatelet therapy after stent implantation--reply.
- Published in:
- 2014
- By:
- Publication type:
- commentary
Dual Antiplatelet Therapy After Stent Implantation.
- Published in:
- 2014
- By:
- Publication type:
- Letter to the Editor
Association between influenza vaccination and cardiovascular outcomes in high-risk patients: a meta-analysis.
- Published in:
- 2013
- By:
- Publication type:
- journal article